Therapeutic Specialist- IBU (関西エリア） at Gilead Sciences

Tokyo, Japan

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Strong commitment to making the best product in advanced treatments that help patients
Experience in JAK inhibitors, biological agents, or rheumatoid arthritis (RA) field
No participation in PIP program (or not currently participating)
Possession of MR (Medical Representative) qualification
Nice to have
Experience in partner business (co-promotion)
Proactivity in voicing opinions/proposals and taking initiative
Ability to tackle challenging problems or new tasks with a challenging spirit and perseverance to achieve goals

Responsibilities

Achieve sales targets
Enhance medical professionals' understanding of product characteristics and positioning
Execute various KPIs (planned visits, communication with physicians, communication with partners)
Contribute to the business unit: share acquired knowledge, share knowledge/experience with team, engage in proposal activities
Conduct events independently or in collaboration with marketing department
Collect insights from medical professionals, market trends, and other information

Skills

Key technologies and capabilities for this role

JAK阻害剤関節リウマチMR資格営業プロモーションKPI管理医療従事者対応市場インサイトチーム連携

Questions & Answers

Common questions about this position

What are the must-have requirements for this Therapeutic Specialist role?

Candidates must have a strong commitment to making the best product in advanced treatments that help patients, experience in JAK inhibitors, biologics, or rheumatoid arthritis, no participation in the PIP program, and hold an MR qualification.

What nice-to-have skills or experiences are preferred for this position?

Preferred experiences include partner business (co-promotion), proactivity in sharing opinions and taking initiative, and the ability to tackle challenging problems with persistence and a challenging spirit.

What is the reporting structure for this role?

The Therapeutic Specialist reports to the Regional Director (RD) of the Inflammation Business Unit and works full-time in a multi-functional team environment.

What are Gilead's core values that employees are expected to uphold?

Gilead's core values are Integrity (Doing What’s Right), Inclusion (Encouraging Diversity), Teamwork (Working Together), Accountability (Taking Personal Responsibility), and Excellence (Being Your Best).

Is this position remote or does it require specific location?

This information is not specified in the job description.

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free